Redpenguin is in a new study now...see quote...
Quote:
|
So - now I'm doing this study on Ocrelizumab. It's a double blind study with Rebif. I either get the Ocre or the rebif. Of course, being that rebif has terrible side effects - i will probably very quickly know which group i'm in (both groups have an IV drip - which would be the Ocre or the placebo and both groups shoot up with rebif or placebo 3x a week).
|